Skip to content

Clinical observation of electroacupuncture in improving PSD and its mechanism based on inflammatory factors

Observation of clinical efficacy of electroacupuncture in improving PSD and exploring its mechanism based on inflammatory factors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072576
Enrollment
Unknown
Registered
2023-06-16
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke depression

Interventions

EA group:electroacupuncture treatment
ESE group:oral medicine

Sponsors

Yancheng Third People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inpatients with a confirmed diagnosis of ischaemic stroke (CIS) by cranial CT or MRI; first episode; duration of illness 3 months to 1 year; at least 2 post-stroke functional deficits; age 20-75 years; meeting the Chinese Classification and Diagnostic Criteria of Mental Disorders, 3rd edition (CCMD-3), Diagnostic and Statistical Manual of Mental Disorders (DSM-V), diagnosed by a specialist psychiatrist as PSD; Hamilton HAMD-17 scale score of 7 to 24 (mild to moderate depression); normal cognition and able to cooperate in completing the assessment scale; no history of serious heart, liver or kidney disease and history of epilepsy, glaucoma and psychosis or medication use; those who voluntarily participated in the study, signed the informed consent form and passed the hospital ethics committee.

Exclusion criteria

Exclusion criteria: People with aphasia and severe cognitive impairment who are unable to cooperate with the examination; combined history of psychiatric disorders such as depression, bipolar disorder, mania; history of alcoholism, epilepsy, post-traumatic stress; unstable vital signs or combined with other serious underlying illnesses; patients with multiple strokes; HAMD-17 total score = 25 or suicidal or self-harming tendencies; participants in other clinical trial studies in the last 3 months.

Design outcomes

Primary

MeasureTime frame
HAMD-17;

Secondary

MeasureTime frame
Depression Symptoms Quick Self-Rating Scale (QIDS-SR16);

Countries

China

Contacts

Public ContactMa Feixiang

Yancheng Third People 's Hospital

63368533@qq.com+86 159 6193 2171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026